CME Activities

Online Programs

Mar
29
Fri
In Pursuit of Better Outcomes in Rheumatoid Arthritis: Inhibiting Inflammatory Pathways With Newer Models of Therapy
Mar 29 2019 @ 12:00 am Mar 29 2020 @ 12:00 am

FACULTY

Vivian Bykerk, BSc, MD, FRCPC
Rheumatologist
Hospital for Special Surgery
Associate Professor of Medicine
Director, Inflammatory Arthritis Center of Excellence
Weill Cornell Medical College
New York, NY

PROGRAM OVERVIEW

This online activity is focused on the team involved in the management of patients with rheumatoid arthritis.

TARGET AUDIENCE

This activity is designed to meet the educational needs of primarily rheumatologists with a secondary audience of internists and allied healthcare professionals involved in the management of patients with rheumatoid arthritis.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Discuss the role of inflammatory cytokines in the pathogenesis of rheumatoid arthritis that results in its complex phenotype
  • Review the international medical society treatment recommendations and the supporting clinical data for patients with moderate-to-severe rheumatoid arthritis
  • Evaluate the incorporation of interleukin-6 therapy to inhibit the progression of structural damage in patients with moderate-to-severe RA
  • Describe the diversity in patient populations with rheumatoid arthritis and its effects on management and treat-to-target goals

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.0 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with RA. Credits: 1.0 ANCC Contact Hours.

CNE Accreditation Statement:
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG‐sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTEREST

Dr. Vivian Bykerk has received consulting fees from Amgen, fNIH, Pfizer, UCB, Scipher, and Sanofi Regeneron.

CME content review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE content review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group, has nothing to disclose.
Ana Maria Albino, Program Manager of Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes of Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA‐approved and non‐approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures.
2. Participate in the online activity.
3. Submit the evaluation form to Med Learning Group.

Participants will receive their certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement
information at http://medlearninggroup.com/privacy‐policy/

RELEASE DATE: March 29, 2019

EXPIRATION DATE: March 29, 2020

Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.

Nov
22
Fri
A 3D View – Inhibiting Structural Damage in Rheumatoid Arthritis: Reducing Inflammation With Targeted Therapies
Nov 22 2019 @ 7:12 am Nov 22 2020 @ 8:12 am

A 3D View – Inhibiting Structural Damage in Rheumatoid Arthritis: Reducing Inflammation With Targeted Therapies

FACULTY

Daniel E. Furst, MD, MACR
Professor Emeritus of Rheumatology and Medicine
University of California, Los Angeles
University of Washington, Seattle WA
University of Florence, Florence, Italy

Joel Kremer, MD, MACR
Pfaff Family Professor of Medicine
Albany Medical College
Albany, New York

PROGRAM OVERVIEW

This case-based online activity will cover the treatment and management of patients with treatment-resistant rheumatoid arthritis.

TARGET AUDIENCE

This enduring activity is designed to meet the educational needs of primarily rheumatologists with a secondary audience of internists and allied healthcare professionals involved in the care of patients with rheumatoid arthritis.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

  • Review clinical trial data supporting medical society recommendations for patients with treatment-resistant RA
  • Review current guidelines for RA, with focus on diagnosis and treating-to-target
  • Describe the role of inflammatory cytokines in the pathogenesis of RA, both articularly and systemically
  • Discuss the use of cytokine inhibition, with focus on IL-6, as a treat-to-target strategy in patients with treatment-resistant RA.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this online activity for a maximum of 1.5 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the long-term treatment and management of patients with rheumatoid arthritis.
CNE Credits: 1.5 ANCC Contact Hours.

ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing. Awarded 1.5 contact hour(s) of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturers of any commercial products and/or providers of commercial services that are discussed in an educational activity.

DISCLOSURE OF CONFLICTS OF INTERESTS

Daniel E. Furst, MD, is a consultant with Actelion, Amgen, BMS, Corbus, Galapagos, Novartis and Pfizer. He reports other relationships with Actelion, Amgen, BMS, Corbus, Galapagos, GSK, NIH, Novartis, Pfizer, Roche/Genentech, and Sanofi.

Joel Kremer, MD, MACR, is a consultant with AbbVie, BMS, Gilead, Lilly, Pfizer, and Regeneron. He reports stock ownership in Corrona, LLC.

CME Content Review
The content of this activity was independently peer reviewed.

The reviewer of this activity has nothing to disclose.

CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.

The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity.

Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development of Med Learning Group has nothing to disclose.
Ashley Whitehurst, Program Manager of Med Learning Group has nothing to disclose.
Chris Drury, Medical Director of Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes of Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Complete pre-and-post survey.
4. Submit the evaluation form online.
You will receive your certificate as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are science-based.
This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/

RELEASE DATE: November 22, 2019

EXPIRATION DATE: November 22, 2020

CLICK ON STATES TO SEE ACTIVITIES

Online offerings provide virtual, faculty-led presentations you can view from your own computer or smart device.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. These CME activities are planned and produced in accordance with the ACCME Essentials.